Copeland Capital Management LLC Has $12.82 Million Holdings in UnitedHealth Group Incorporated $UNH

Copeland Capital Management LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.8% during the second quarter, Holdings Channel.com reports. The firm owned 41,095 shares of the healthcare conglomerate’s stock after acquiring an additional 4,977 shares during the quarter. Copeland Capital Management LLC’s holdings in UnitedHealth Group were worth $12,821,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Bayforest Capital Ltd boosted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the first quarter valued at $42,000. Kentucky Trust Co boosted its position in UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after acquiring an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC boosted its position in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after acquiring an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Barclays upped their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Bank of America upped their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a report on Monday, August 18th. Finally, Robert W. Baird restated an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Trading Up 1.4%

Shares of UNH stock opened at $353.26 on Friday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50-day simple moving average of $306.25 and a two-hundred day simple moving average of $356.57. The company has a market capitalization of $319.94 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 2.27 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the company posted $6.80 earnings per share. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.